Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

Eli Lilly ( LLY 0.64%) has been one of the best-performing pharmaceutical leaders in the past five years. Thanks to strong ...

Insiders have been trading these 5 stocks: (($LLY)), (($MCD)), (($MRVL)), (($DAL)) and (($RTX)). Here is a breakdown of their recent trades and ...

Assessing Eli Lilly's Performance Against Competitors In Pharmaceuticals Industry November 05, 2024 — 10:00 am EST Written by Benzinga Insights for Benzinga -> ...

Eli Lilly (NYSE: LLY) stock has soared 90% over the past year, a huge gain for a pharmaceutical company. ... As a result, Lilly's earnings and stock performance have surged.

However, when looking at the fundamental performance of these two, I don’t see many reasons for the stock outperformance of Eli Lilly. At best, we can call it a head-to-head race.

Eli Lilly (LLY) is experiencing a banner year, as its stock price has reached new all-time highs in June. The surge comes on the heels of a series of positive developments for the pharmaceutical ...

Eli Lilly's stock isn't cheap The company's stock trades at a hefty 39 times forward earnings. That's very high for a pharma company and more than twice its main GLP-1 competitor, Novo Nordisk .

Leerink Partners analyst David Risinger has reiterated their bullish stance on LLY stock, giving a Buy rating today. Geoff Meacham has given his Buy rating due to a combination of factors ...

Eli Lilly (LLY 0.16%) stock has soared 90% over the past year, ... Lilly's recent earnings and stock performance successes have left it trading for 62x times forward earnings estimates.